The Merger of Datavant and Ciox Health Creates the Largest Neutral and Secure Health Data Ecosystem

Datavant | June 10, 2021

Datavant, the leader in assisting healthcare organizations in securely connecting their data, and Ciox Health, the leader in clinical data exchange, announced that they had signed a formal agreement to merge the two companies in a $7.0 billion transaction. The combined entity, known as Datavant, will be the nation's largest health data ecosystem, allowing patients, providers, payers, health data analytics companies, patient-facing applications, government agencies, and life science business owners to share patient-level data securely.


The combined company aims to improve patient outcomes and save costs by eliminating barriers to the secure exchange of health data. Datavant will enable hundreds of companies in its ecosystem to access, exchange, and connect data for use cases ranging from enhanced clinical care and value-based payments to health analytics and medical research.


Datavant's combined ecosystem will now include:

•    More than 2,000 U.S. hospitals and more than 15,000 clinics
•    More than 120 health plans
•    More than 100 health data analytics companies
•    More than 30 life science companies
•    More than 70 academic institutions and non-profits
•    More than 75 states, local, and federal government agencies


An existing investor group of private equity, venture capital, and strategic investors led by New Mountain Capital, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & Johnson Innovation – JJDC, Inc., and Flex Capital is supporting the transaction. It also includes substantial new investment from Sixth Street and participation from Goldman Sachs Asset Management's West Street Strategic Solutions fund. After the acquisition is completed, Sixth Street will join the new company's Board of Directors.


After the transaction is completed, the new company will be managed by current Ciox CEO Pete McCabe as CEO, and current Datavant CEO Travis May will assume the post of President and join the Board of Directors.


The merger is subject to regulatory approval and is scheduled to close in the third quarter of 2021. New Mountain and Ciox were advised financially by Deutsche Bank, Goldman Sachs, and Triple Tree. New Mountain and Ciox were represented by Ropes & Gray LLP, while Goodwin Procter LLP represented Datavant. Sidley Austin LLP represented sixth Street and Goldman Sachs.


About Datavant

The objective of Datavant is to connect the world's health data to enhance patient outcomes. Datavant strives to eliminate the friction associated with data sharing in the healthcare industry by developing technology that protects patients' privacy while linking de-identified patient records across datasets. Datavant is based in San Francisco.


About Ciox Health

The Ciox platform connects data, improves patient outcomes, and lowers healthcare costs by using the industry's most extensive clinical data network. Ciox connects healthcare decision-makers to the data and hidden insights in patient medical records simply and safely. Ciox's solutions for data acquisition, information release, clinical coding, and data abstraction assist customers in safely and consistently resolving last mile challenges in healthcare interoperability to serve various needs ranging from research to the revenue cycle.


Because waits, delays, and cancellations are so common in health care, patients and providers assume that waiting is simply part of the care process. But recent work on assessing the reasons for delays suggests otherwise.


Because waits, delays, and cancellations are so common in health care, patients and providers assume that waiting is simply part of the care process. But recent work on assessing the reasons for delays suggests otherwise.

Related News


SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical Enhancing and Consolidating the Patent Portfolio

SyMap | December 30, 2021

SyMap Medical Ltd (SyMap) announced its strategic collaboration with Pythagoras Medical. With this win-win collaboration, SyMap has full rights to utilize all assets of Pythagoras, including their Renal Nerve Mapping System (ConfidenHT™, CE Mark Approval,) patents, trademarks and expertise. This collaboration will further enhance and consolidate the patent portfolio of SyMap and ensure the leading position of SyMap in the domain of Renal Denervation (RDN). SyMap is focused on developing revolutionary device therapies for the unmet clinical needs of cardiovascular and pulmonary diseases, including hypertension, heart failure, arrhythmia, asthma and early-stage lung cancer. The company, co-founded by Dr. Jie Wang and Mr. Kewen Jin, is based in bioBAY, located in Suzhou, China. Dr. Wang has a long track record of academic research and entrepreneurship. He is a faculty member of the College of Physicians & Surgeons of Columbia University, professor at the Jiangsu Province Hospital and is the former Dean of Nanjing University's medical school. He has participated in the development of RDN since the technology's infant stages via Ardian Inc. SyMap is conducting two pivotal trials in China: the first is the SMART Studyusing the SyMapCath I™ Catheter/SYMPIONEER S1™ RF system for the treatment of uncontrolled hypertension. This system is based on proprietary technology and is able to map renal nerves for selective renal sympathetic denervation as well as provide feedback for physicians before, during, and after the procedure. The second trial is the BATA Studywhich assesses the efficacy and safety of the Elation™ system to treat severe asthma via bronchial radiofrequency ablations. Both studies are executed by leading clinical investigators and are guided by well-known international experts who serve on the company's Scientific Advisory Boards. Both systems have been granted "Green Channel Device" status by China's regulatory agency. Pythagoras Medical is a cutting-edge medical device company established by Rainbow Medical, Israel's premier medical device investment group. The company is developing a platform for intra-arterial nerve mapping using an electrical stimulation approach for hypertension. Its ConfidenHT™ System has received CE Mark in EU countries.

Read More


Reliq Health Technologies, Inc. Partners with Data Soft Logic to Add over 50,000 New Patients per Year to Reliq’s iUGO Care Platform

Reliq Health | January 25, 2022

Reliq Health Technologies Inc. (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced an agreement with Data Soft Logic (DSL) to provide iUGO Care to their existing and new clients. The Data Soft Logic platform is a cloud-based home health and hospice care solution that provides a suite of applications including point of care, billing, scheduling, accounting and human resources. The platform is used currently used by over 600 home health and hospice care agencies across the United States. Data Soft Logic’s home health and hospice clients work with over 1,000 primary care physicians who provide care to over 500,000 Medicare and Medicaid patients. “We are thrilled to be working with Data Soft Logic on this highly synergistic partnership. Reliq will be providing our iUGO Care remote patient monitoring (RPM), remote therapeutic monitoring (RTM), chronic care management (CCM), behavioral health integration (BHI) and transitional care management (TCM) software and services to Data Soft Logic’s home health agency and hospice provider clients throughout the United States. Reliq’s own home health and hospice clients will benefit from having the option of fully integrated access to Data Soft Logic’s exceptional, comprehensive practice management platform. Through this partnership, Reliq expects to begin onboarding patients in Q2 2022 and to ramp up to adding over 50,000 new patients per year to our platform in 2023, at an estimated revenue of $60 per patient per month.” Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. About Data Soft Logic Data Soft Logic Corporation is a cloud-based home health care and Hospice solution offering a suite of applications including Point of Care, Symptom Management, Billing, Scheduling, Accounting and Human Resources. Data Soft Logic software is powerful and meaningful with simplicity of use for superior connected care at point of delivery. We are proud to have partnered with home health, hospice, and therapy agencies for over 10 years. Reliq Health Reliq Health Technologies is a rapidly growing global healthcare technology that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

Read More


Charter Healthcare Selects Netsmart Platform to Transform Post-Acute Care Services

Charter Healthcare | June 19, 2021

Charter Healthcare, a provider of post-acute care services offering a broad spectrum of programs for patients navigating the last years of life, has selectedNetsmartas their healthcare information technology partner to implement solutions that are part of the integrated NetsmartCareFabric®platform. This partnership will enhance Charter’s ability to provide patient-centered hospice, home health, complex care management and palliative care services through improved workflows and access to complete historical patient electronic health records (EHR) on a single enterprise platform. Charter clinicians and staff will utilize the NetsmartmyUnity®EHR solution, the industry’s first unified EHR platform that enables organizations to manage multiple business lines spanning numerous care settings within a single patient record. This solution allows an individual’s information to travel with them as they transition care settings, giving providers insight into a person’s complete health history. Charter will leverage referral management, clinical decision support and the powerfulNetsmart networkandCarequalityinteroperability framework to seamlessly share and exchange data with health information exchanges and providers across the healthcare ecosystem. “Charter Healthcare is dedicated to improving patient outcomes and quality care. We chose Netsmart because of their reputation in the post-acute care space and commitment to connecting care for the individuals and families we serve,” explained Charter Healthcare CEO Steve Larkin. “The ability to use one comprehensive integrated platform with robust functionalities helps us gain a truly holistic view of those we serve and enables our staff to make meaningful decisions for the medically fragile patients within our care. In a world where staffing needs are great, the myUnity clinician experience gives us an advantage in the market.” The partnership with Netsmart will also help Charter achieve its long-term vision for growth and development by providing tools to augment its accessibility among referral and facility partners. The organization will implement Netsmart Mobile CareGiver+, an integratedelectronic visit verification(EVV) solution, for mobile care delivery to verify provider visits for personal or home-based services. Additionally, Charter will leverage the NetsmartReferral Managerto digitize and enhance their referral pipeline, reducing time spent responding to inquiries while creating a robust partnership database. “Netsmart is committed to equipping Charter Healthcare with the tools to elevate their services across the post-acute care continuum for its patients, families, providers, employees and referral partners,” said Netsmart CEO Mike Valentine. “Healthcare organizations often place additional burdens on clinicians and staff to manually coordinate between different care settings. Charter has streamlined this process by leveraging Netsmart technology to enhance their team’s ability to coordinate value-based care more efficiently and effectively. We look forward to our continued partnership as together we work to improve and streamline processes to enhance the post-acute care continuum and improve patient outcomes and quality care.” About Charter Healthcare Charter Healthcare is committed to delivering high quality services that enhance the post-acute care continuum by providing compassionate, innovative and accessible healthcare solutions for patients and their families. Over more than a decade, we’ve earned our reputation as a premier full-spectrum care provider that helps patients navigate the last four years of life with services including home health, complex care management, palliative care, and hospice. Founded in southern California, Charter Healthcare now serves more than 4,500 patients in seven states. About Netsmart Netsmart, a leading provider of Software as a Service (SaaS) technology and services solutions, designs, builds and delivers electronic health records (EHRs), health information exchanges (HIEs), analytics and telehealth solutions and services that are powerful, intuitive and easy-to-use. Our platform provides accurate, up-to-date information that is easily accessible to care team members in the human services and post-acute care (which is comprised ofhome careandhospiceandsenior living) markets. We make the complex simple and personalized so our clients can concentrate on what they do best: provide services and treatment that support whole-person care.

Read More